CAPR

CAPR

USD

Capricor Therapeutics Inc. Common Stock

$6.060+0.005 (0.083%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$6.055

Hoch

$6.410

Tief

$6.000

Volumen

0.58M

Unternehmensfundamentaldaten

Marktkapitalisierung

277.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.33M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $5.68Aktuell $6.060Hoch $20.75

Ähnliche Nachrichten

GlobeNewswire

Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel

–Publication highlights Deramiocel's anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, 2025 (GLOBE

Mehr anzeigen
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
GlobeNewswire

Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10

SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today

Mehr anzeigen
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
PR Newswire

Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ:...

Mehr anzeigen
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.